BrainStorm Cell Therapeutics (BCLI) - Cost to borrow shares

Latest borrow fee for BrainStorm Cell Therapeutics (BCLI) shares on Interactive Brokers: 42.3833% (annualized)

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

BrainStorm Cell Therapeutics (BCLI) - cost to borrow in the last 7 days chart

BrainStorm Cell Therapeutics (BCLI) - number of shares available to borrow in the last 7 days

BrainStorm Cell Therapeutics (BCLI) - cost to borrow from 2024 to 2023

BrainStorm Cell Therapeutics (BCLI) - number of shares available to borrow from 2024 to 2023

Cost to borrow for shares of similar companies or competitors

Company	Cost to borrow (% year)	Shares available	Country
Gilead Sciences GILD	0.25%	10 M	🇺🇸 USA
Cytokinetics CYTK	0.4081%	3.8 M	🇺🇸 USA
Seagen SGEN	0.25%	2.2 M	🇺🇸 USA
Biogen BIIB	0.4081%	4.3 M	🇺🇸 USA
Agenus AGEN	1.0638%	0.25 M	🇺🇸 USA